Personalized Treatment for Scalp Angiosarcoma
Journal of Clinical Medicine · 14.02.2025 · 14 (4) · 1278
DOI: 10.3390/jcm14041278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.02.2025. Verfasst von Adriana Nicoleta Cristescu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Elias Emergency University Hospital, 17 Marasti Bd., District 1, 011461 Bucharest, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila.
Abstract (Originalsprache)
Cutaneous angiosarcoma is a rare and aggressive malignant tumor that originates from the endothelial cells of blood vessels or lymphatic vessels. More than half of cutaneous angiosarcoma cases occur in the head and neck regions, particularly on the scalp. However, due to its rarity, scalp angiosarcoma is often overlooked in clinical practice. The lack of distinctive symptoms usually delays the diagnosis and, implicitly, the initiation of appropriate treatment. The treatment of cutaneous angiosarcoma poses great challenges due to its multifocal occurrence and the frequent extensive microscopic spread. A personalized, multimodal therapeutic approach is essential for ensuring a favorable outcome, consisting of a wide surgical excision associated with adjuvant radiotherapy in localized tumors, concurrent adjuvant radiotherapy and chemotherapy, targeted treatments, or immunotherapy in advanced or metastatic diseases. The aim of this manuscript is to review the literature data regarding the individualized management of cutaneous angiosarcoma and to share our own experiences in the field. We wish to underscore the importance of considering cutaneous angiosarcoma in the differential diagnosis of scalp tumors, especially in patients with a history of scalp irradiation as early detection, accurate diagnosis, and a multidisciplinary, personalized management, including surgery with clear margins and adjuvant radiation therapy, are crucial for ensuring a favorable outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Elias Emergency University Hospital, 17 Marasti Bd., District 1, 011461 Bucharest, Romania.
- General Surgery Department, Prof. Dr. Dimitrie Gerota Emergency Hospital, 29-31 Vasile Vasilievici Stroescu Street, District 2, 021374 Bucharest, Romania.
- Histopathology Department, Elias Emergency University Hospital, 17 Marasti Bd., District 1, 011461 Bucharest, Romania.
- Dermatology Department, Carol Davila University of Medicine and Pharmacy, 37 Dionisie Lupu Street, District 1, 020021 Bucharest, Romania.
- D-Clinic, 2B Avrameni Street, District 1, 013738 Bucharest, Romania.
ORCID-Profile: Cristina Beiu, Liliana Gabriela Popa
Förderung
- University of Medicine and Pharmacy Carol Davila
Zitieren
APA
Cristescu, A. N., Dumitrescu, I., Tudose, I., Beiu, C., Dumitrescu, A. M., & Popa, L. G. (2025). Personalized Treatment for Scalp Angiosarcoma. Journal of Clinical Medicine, 14(4), 1278. https://doi.org/10.3390/jcm14041278
Vancouver
Cristescu AN, Dumitrescu I, Tudose I, Beiu C, Dumitrescu AM, Popa LG. Personalized Treatment for Scalp Angiosarcoma. Journal of Clinical Medicine. 2025;14(4):1278. doi:10.3390/jcm14041278
BibTeX
@article{Cristescu2025,
author = {Cristescu, Adriana Nicoleta and Dumitrescu, Ioana and Tudose, Irina and Beiu, Cristina and Dumitrescu, Ana-Maria and Popa, Liliana Gabriela},
title = {Personalized Treatment for Scalp Angiosarcoma},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {4},
pages = {1278},
doi = {10.3390/jcm14041278}
}
EUVIMED